Compugroup Medical (COP) PT Set at €53.00 by Commerzbank

Compugroup Medical (ETR:COP) has been given a €53.00 ($61.63) price target by equities research analysts at Commerzbank in a report released on Thursday. The brokerage currently has a “buy” rating on the stock. Commerzbank’s target price would indicate a potential upside of 14.87% from the company’s previous close.

A number of other research firms also recently issued reports on COP. Baader Bank set a €46.00 ($53.49) price target on Compugroup Medical and gave the stock a “neutral” rating in a research note on Thursday, August 9th. Hauck & Aufhaeuser set a €36.00 ($41.86) price target on Compugroup Medical and gave the stock a “sell” rating in a research note on Friday, August 31st. Warburg Research set a €53.50 ($62.21) price target on Compugroup Medical and gave the stock a “buy” rating in a research note on Friday, August 10th. Deutsche Bank set a €62.00 ($72.09) price target on Compugroup Medical and gave the stock a “buy” rating in a research note on Tuesday, August 14th. Finally, Berenberg Bank set a €49.00 ($56.98) price target on Compugroup Medical and gave the stock a “neutral” rating in a research note on Monday, August 13th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Compugroup Medical currently has a consensus rating of “Hold” and a consensus price target of €51.79 ($60.22).

COP stock opened at €46.14 ($53.65) on Thursday. Compugroup Medical has a 1 year low of €40.10 ($46.63) and a 1 year high of €60.30 ($70.12).

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Further Reading: Understanding Price to Earnings Ratio (PE)

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit